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ABSTRACT
Background A key component of strategies to reduce antimicrobial resistance is better antimicrobial prescribing. The majority of antibiotics are
prescribed in primary care. While many existing surveillance systems can monitor trends in the quantities of antibiotics prescribed in this setting,
it can be difﬁcult to monitor the quality of prescribing as data on the condition for which prescriptions are issued are often not available. We
devised a standardized methodology to facilitate the monitoring of condition-speciﬁc antibiotic prescribing in primary care.
Methods We used a large computerized general practitioner database to develop a standardized methodology for routine monitoring of
antimicrobial prescribing linked to clinical indications in primary care in the UK. Outputs included prescribing rate by syndrome and percentages
of consultations with antibiotic prescription, for recommended antibiotic, and of recommended treatment length.
Results The standardized methodology can monitor trends in proportions of common infections for which antibiotics were prescribed, the
speciﬁc drugs prescribed and duration of treatment. These data can be used to help assess the appropriateness of antibiotic prescribing and to
assess the impact of prescribing guidelines.
Conclusions We present a standardized methodology that could be applied to any suitable national or local database and adapted for use in
other countries.
Keywords primary care, public health
Introduction
Antibiotic resistance poses a major threat to clinical medi-
cine and public health, not only in the UK but internation-
ally.1–5 It is recognized that overprescribing of antibiotics
generates a strong selective pressure for the emergence and
spread of antibiotic resistance. Hence, promotion of anti-
biotic stewardship programmes, comprising activities aimed
at optimizing prescribing so as to improve clinical outcomes
while minimizing the selective pressure for resistance engen-
dered by antimicrobial use, is increasingly being advocated
as a major intervention for trying to reduce levels of anti-
microbial resistance. For example, optimizing prescribing
practice through implementation of antimicrobial steward-
ship programmes is one of the seven key areas for action
highlighted in the UK 5-Year Antimicrobial Resistance
Strategy.5
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Assessing the implementation and impact of antibiotic
stewardship programmes requires a better understanding of
antimicrobial usage, both in primary and secondary care.
Indeed, both the European Commission4 and the UK’s
Chief Medical Ofﬁcer have highlighted the importance of
surveillance of antimicrobial consumption. However, while
available data on antibiotic use show trends in drug usage by
class6–8 information on why the drug was prescribed is fre-
quently lacking, making it difﬁcult to assess whether or not
prescribing is appropriate or to monitor the effectiveness of
prescribing guidelines. Our previous work has shown how
general practitioner (GP) databases can be used to look at
prescribing for speciﬁc conditions and to assess the impact
of published prescribing guidance.9–11 As an aid to investiga-
tors wishing to use such data sources to develop on-going
surveillance systems at a national or local level, we present
here the development of a standardized methodology designed
to enable the establishment of a system for monitoring anti-
microbial prescribing linked to clinical indications in primary
care. The formulation of the standardized methodology was
based on our experience of conducting a study to assess
trends in compliance of antibiotic prescribing in the com-
munity with national guidance.11
Methodology
The methods presented describe and set out the different
components of the standardized methodology, describing
the various elements required to establish an antimicrobial
prescribing surveillance system.
Data requirements
The key requirement for an antimicrobial prescribing sur-
veillance system is access to a large computerized database
of GP data that records both clinical indicators and pre-
scribing data using validated medical coding systems (e.g.
Read Codes, SNOMED, ICD10).12,13 The computerized
system should be capable of linking consultations and
prescribing data (e.g. by consultation/prescribing date) so
that it is possible to determine the condition for which an
antimicrobial was prescribed. The database should pro-
vide appropriate geographical coverage and data quality
indicators should show when practices meet recording
standards.14,15 Demographic data should be available to
allow surveillance of prescribing trends by age, region or
sex. Finally the database should be regularly updated to
allow surveillance of prescribing trends over time.
In the UK suitable databases include the Health
Improvement Network (THIN),16 the Clinical Practice
Research Datalink (CPRD),17,18 and the Royal College of
General Practitioners Research Surveillance Centre database
(RCGPRSC).19,20 The THIN database collects consultation
data from 587 general practices with 3.6 million active
patients, comprising 5.7% of the UK population16 while
CPRD has 674 practices with 4.4 million active patients,
representing 6.9% of the UK population.21 There is an over-
lap between THIN and CPRD with some practices contrib-
uting to both systems and similar data available in both.22
The RCGPRSC is slightly smaller covering 230 practices and
1.5 million patients that also allows analysis of prescribing
rates for infections.19,20
Clinical indicators
When considering which clinical indicators to monitor it is
preferable to choose conditions commonly recorded in gen-
eral practice for which clear recommendations regarding the
appropriateness of antibiotic prescribing are available. In the
UK, prescribing recommendations have been made to pri-
mary care physicians by a number of authorities including:
the RCGP;23 National Institute for Health and Care
Excellence (NICE);24 the Department of Health’s Standing
Medical Advisory Committee (SMAC) Sub-Group on
Antimicrobial Resistance;25 Public Health England26 (whose
guidelines are endorsed by the Royal College of General
Practitioners) and the British National Formulary.27 Other
countries will have their own recommendations that could
be used to set appropriate indicators.
Methods of data extraction and analysis
It is important that methods of data extraction and analysis
are properly recorded, especially if the intention is to set up
an on-going surveillance system where analysis will be
repeated at regular intervals. An example of suitable soft-
ware is STATA,28 which is able to handle very large datasets.
STATA queries are written as program ‘do ﬁles’ that provide
a permanent record of what was done so that queries can be
repeated at a later date, making it particularly suitable for
on-going surveillance.
Data quality
The quality of GP data depends on the thoroughness of
data recording within the individual practice. Some databases
(e.g. RCGPRSC and THIN) have on-going training in data
recording for participating GPs, while all will carry out data
validation checks and may provide quality indicators for
each practice to show when they reached an acceptable level
of data recording.15,29 The databases should also carry out
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data validation checks on patient records to check that data
on age, sex and other important variables are recorded.29,30
Data extraction
Episodes of the condition of interest can be extracted by
merging patient records with the list of codes chosen to
deﬁne that condition (which may include signs and symp-
toms). Episodes can then be linked to antibiotic prescribing
using the appropriate drug code list. However, there can be
more than one consultation (when antibiotics may or may
not have been prescribed) associated with the same episode
of illness, and many conditions can occur more than once.
If possible, initial and new consultations from an illness epi-
sode should be pooled for inclusion in the analysis to assess
whether an antibiotic was or was not prescribed for that epi-
sode. Given there may be uncertainty as to whether a new
consultation is related to a given episode of illness, inclu-
sion/exclusion periods can be set after the initial consult-
ation to help standardize the criteria for deﬁning episodes in
a given study, particularly if trends in prescribing are being
monitored. Only episodes with a single condition and a sin-
gle prescription issued within the same consultation or on
the same day should be included to be reasonably conﬁdent
that the antibiotic was prescribed for the condition
monitored.
Data analysis
For data analysis, STATA survival analysis commands were
used to calculate incidence rates for total episodes and for
episodes where antibiotics were prescribed over a 16-year
period. In addition annual rates were calculated by sex, age
band and Townsend score,31 a composite measure of social
deprivation linked to UK Census data by patient post code
that is included in the THIN dataset. Data were also pre-
sented as the percentage of episodes where antibiotics were
prescribed. For urinary tract infections (UTIs), for which
current UK prescribing guidelines recommend three day
courses of nitrofurantoin (or trimethoprim if low risk of
resistance) for adult women,26 course lengths were calculated
by dividing the number of tablets prescribed by the daily
dosage. Daily dosage is often recorded as free text but in
THIN this has been converted to a numeric quantity.32
The conditions were deﬁned as groups of clinical codes.
Since THIN records consultations using the Read Clinical
Classiﬁcation version 2, the conditions were deﬁned as lists
of Read codes, but other medical coding systems such as
SNOMED or IDC10 could be used. We conducted an initial
broad search of the Read code dictionary using methods
previously described.33 For each condition, a list of search
terms (key words and synonyms) was produced and used to
search the descriptions in the Read code dictionary to pro-
duce a comprehensive code list from which the ﬁnal codes
to be included were chosen. It is helpful if the codes can be
linked to counts to see how often they are used to ensure
that the most commonly used codes are included. The
selected groups of clinical codes can be chosen to maximize
sensitivity (to include all possible cases) or speciﬁcity. Our
aim was to make the groups of clinical codes as near to the
condition that was subject to a recommended action as pos-
sible and so the following criteria were applied:
− High speciﬁcity of code for clinical condition: e.g. tonsil-
litis was included in the sore throat indicator, but not
inﬂuenza, even though it may present with a sore throat,
since many cases of inﬂuenza will not have a sore
throat.
− Exclusion of codes that indicated a clear bacterial aeti-
ology for recommendations that related to viral upper
respiratory tract infection (URTI) (e.g. exclusion of ‘bac-
terial sore throat’ and ‘streptococcal sore throat’, but
not excluding a generic ‘sore throat’).
− Exclusion of speciﬁc codes for which the relevant recom-
mendation is not appropriate (e.g. the UTI recommenda-
tion was for women with uncomplicated infection, so
infections recorded as recurrent or associated with preg-
nancy or kidney infection were excluded).
A more sensitive, less speciﬁc list could also be analysed to
check that any improvement is not due to ‘diagnostic trans-
fer’34 to more severe clinical codes to justify a prescription.
Drug code lists included all antibiotics in chapter 5.1 of
the British National Formulary27 excluding chapters 5.1.9
(antituberculosis drugs) and 5.1.10 (antileprotic drugs).
Additional code lists were developed for antibiotics speciﬁed
in UK treatment guidelines.26
Resources required for a surveillance system
When setting up a surveillance system it is important to con-
sider cost as this is likely to have a substantial impact on the
feasibility of any project. In the UK most providers meet the
costs of maintaining large GP datasets by charging those
who use the data. The fees vary depending on the level of
access to the data.
At the beginning of a project, staff time is required to
produce code lists, set up and check queries for data extrac-
tion and develop surveillance reports. Clinical/Consultant
Epidemiologist input may be required to agree the ﬁnal
code lists for the indicators and drug code lists, and it can
be helpful if GPs with expertise in GP data or antimicrobial
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resistance are available to comment on these. Someone with
a thorough knowledge of statistical packages is necessary, to
check the data queries and oversee the statistical outputs.
Once the initial work is complete, an on-going surveillance
system would require the analysis to be repeated at regular
intervals, probably either annually or quarterly.
Results
Example of use of the standardized methodology
for analysis of THIN data
We present here speciﬁc details of use of the standardized
methodology based on our experience of conducting a pilot
UK study of community prescribing for cough/cold, sore
throat, URTI, otitis media and UTIs, using data from the
THIN database.11,16 These conditions were chosen as they
covered recommendations for infections for which antibiotic
prescribing should be avoided, conditions when speciﬁc anti-
biotics should be given and one instance (UTIs) of a recom-
mendation for short-course prescribing.26
Data outputs
Outputs for selected clinical syndromes have been reported
elsewhere.11 Four types of indicator were produced:
− Prescribing rate by syndrome.
− Percentage of consultations for the condition that
resulted in an antibiotic prescription.
− Percentage of antibiotic prescriptions for the condition
that were for one of the recommended antibiotics.
− Percentage of antibiotic prescriptions for the condition
that were of the recommended treatment length.
These indicators can be analysed by:
− Time trends.
− Variation by individual primary care practice.
− Age-group.
− Socio-economic group.
Figure 1 shows an example output from using the standar-
dized methodology, illustrating trends in both incidence and
in prescribing for one of the selected conditions and shows
the importance of considering both sets of data together.
This example shows a marked decline in the rate of anti-
biotic prescribing for episodes of URTI between 1995 and
2000, but also shows a similar decline in incidence of URTI,
suggesting that this decrease could be due to less morbidity
presenting to the physician, rather than a change in
prescribing behaviour. It is therefore useful to also look at
the percentage of episodes with an antibiotic prescribed.
When the data are presented in this way there remains a sig-
niﬁcant decline in the percentage of episodes with a pre-
scription from 64% in 1996 to 49% in 1999 (Fig. 2) but
there is also a dip to 47% in 2009, the year of the inﬂuenza
A(H1N1)pdm09 ‘swine ﬂu’ pandemic, that is not obvious in
Fig. 1.
The standardized methodology enables data to be further
stratiﬁed by age band and socio-economic group to examine
variations in prescribing. The example in Fig. 3 shows that
the 0–4 years age group are far less likely to be prescribed
an antibiotic for URTI than other age groups, while those
65 years and over had the highest percentage of antibiotics
prescribed. There was little difference in prescribing by
socio-economic group although the most deprived patients
(group 5) were slightly less likely to be prescribed antibiotics
(Fig. 4). Example outputs from the ﬁnal two types of indica-
tor are provided in Supplementary material (Figs S1 and S2).
Using the standardized methodology it is also possible to
look at the individual drugs prescribed for a condition to see
if they are in line with the recommendations in current pre-
scribing guidance. For example, although 60% of otitis media
cases should resolve in 24 h without antibiotics, where they
are prescribed UK treatment guidelines recommend amoxi-
cillin, or erythromycin for those with penicillin allergy.26
Although the percentage of episodes of otitis media with
an antibiotic remained stable, there was an increase in the
percentage of prescriptions for a recommended antibiotic
from 77% in 1995 to 85% in 2011 (data not shown). This
approach could also be adapted to examine prescribing
of an inappropriate antibiotic, e.g. prescribing of broad-
spectrum cephalosporins may be discouraged in some
countries to reduce Clostridium difﬁcile infections.26
To assess whether this dataset could produce useful data
to help monitor recommendations for short-course therapy
in certain syndromes, we looked at course length for tri-
methoprim or nitrofurantoin in UTIs. Although there was
no speciﬁc data ﬁeld for course length, we were able to cal-
culate this from the ‘quantity prescribed’ ﬁeld divided by the
‘calculated daily dosage’ ﬁeld for 81 and 70%, respectively,
of episodes for which these antibiotics were prescribed. This
showed a signiﬁcant increase in short-course therapy, in line
with national recommendations.
Discussion
Main ﬁnding of this study
We have developed a standardized methodology for using
data from a GP database to monitor trends in antibiotic
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prescribing for speciﬁc clinical indications, and have given
an example of its use to show trends in diagnosis and anti-
biotic prescribing for a series of chosen conditions over recent
years. These data could be regularly updated to provide an
on-going surveillance system. While there are a number of
surveillance systems that monitor trends in the quantity of
antibiotics prescribed in primary care, the lack of information
on the condition for which the prescription was issued makes
it difﬁcult to monitor the quality of prescribing. The standar-
dized methodology can monitor trends in prescribing for spe-
ciﬁc conditions, including looking at speciﬁc drugs prescribed
and the duration of treatment. The data can be used to help
assess the appropriateness of antibiotic prescribing and
also to evaluate the impact of prescribing guidelines.
Fig. 1 URTI all episodes and episodes with antibiotic prescribed, 1995–2011.
Fig. 2 Percentage of episodes of URTI with antibiotic prescribed, 1995–2011 (with 95% conﬁdence intervals for within practice year on year variation).
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What is already known on this topic
Although our pilot study used the THIN dataset available in
the UK, similar primary care databases also exist in other
European countries, such as the Information System for the
Development of Research in Primary Care (SIDIAP) in
Catalonia,35 or the Health Search Database (HSD) in Italy.36
Although some of these datasets are smaller than THIN,16
they are sufﬁciently large and well-established to be used to
examine national consultation and prescription trends in
infectious diseases, offering the potential for a powerful
international infectious disease surveillance network.
What this study adds
To aid local antibiotic stewardship programmes, Public
Health England has recently extended the range of public
Fig. 3 Percentage of episodes of URTI with antibiotic prescribed stratiﬁed by age band (years), 1995–2011.
Fig. 4 Percentage of episodes of URTI with antibiotic prescribed stratiﬁed by Townsend score, 1995–2011.
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health proﬁles available on its freely accessible Fingertips
web-portal to include antimicrobial resistance.37 This allows
local data on antibiotic prescribing (both total and by anti-
biotic class) to be accessed by Clinical Commissioning
Groups, Trusts or GP practices, who can also benchmark
their prescribing against the national picture. The value of
the standardized methodology reported here is that it can
enhance understanding of data available via Fingertips
through its ability to link antibiotic prescribing data to clin-
ical indications, thus allowing users not only to monitor
trends in prescribing but also the quality in terms of appro-
priate or inappropriate antibiotic use.
Limitations of this study
There can be limitations to the use of the standardized
methodology such as the choice of clinical codes to deﬁne
the conditions to be monitored. For example, omission of
any commonly used codes would result in erroneous inci-
dence rates. Similarly if GPs changed the way that they code
conditions over time, possibly to justify issuing prescriptions,
this could affect analysis of trends in prescribing.34
When auditing the content of computerized records it is
necessary to consider the consistency and comprehensive-
ness of the record generated. A satisfactory record must
always contain the Read codes relevant to the morbidity for
which the person consulted and for which the antibiotic or
other drug was prescribed linked together on the same date.
Prescriptions are routinely issued from (and therefore stored
on) computer records but if morbidity details and relevant
Read codes are not entered at the same time it may prove
impossible to audit prescription linked morbidity. We there-
fore emphasize the importance of disciplined recording as a
prerequisite for audit activities.
Prescribing data are particularly well recorded in THIN
because the record in the practice information system dir-
ectly generates the paper prescription, although there is no
way of knowing whether or not the prescription was dis-
pensed. Hence, the system cannot identify cases where the
GP has followed guidelines and issued a deferred prescrip-
tion to be used only if there is no improvement: this could
mean that antibiotic usage may be overestimated.
A further limitation of the system is that it would miss
prescribing not entered on the practice information system.
One of the key areas is the clinical management of patients
through GP out of hours (OOH) services. The electronic
record of a patient who consults OOH services, and is pre-
scribed an antibiotic, may not be updated with prescribing
information that is readily extractable, and therefore not
available for analysis. This could also include prescriptions
issued when a GP visited a patient at home.
Finally it is known that some prescribed antibiotics are
not linked to a clinical code and therefore the reason for the
prescription is unknown (estimated to include ~39% of anti-
biotics prescribed).38
Conclusion
Monitoring antimicrobial prescribing is a major component
of strategies for the control of antimicrobial resistance pro-
duced at local, UK,5 European4 and World2 level. We have
described a methodology for monitoring antibiotic prescrib-
ing using data from a large GP database, which has been
put together in the form of a standardized methodology that
can be modiﬁed to be used in any county that has a suitable
database of primary care consultations. The adoption and
use of this standardized methodology will contribute to the
implementation and monitoring of antimicrobial stewardship
initiatives to help deliver these strategies.
Supplementary data
Supplementary data are available at the Journal of Public
Health online.
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